Emmanuel Stip is an expert in Psychiatry at Hôpital Louis-H Lafontaine (Canada). As of October 2026, ScienceLeadR ranks Emmanuel Stip in the top 1% of experts worldwide for Schizophrenia and Schizophrenia Spectrum and Other Psychotic Disorders. Emmanuel Stip has authored 440 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 1 of them ongoing. SLR score: 1,262 (community average: 125). How the SLR is computed.

LeadR Profile

Emmanuel Stip Hôpital Louis-H Lafontaine Canada
1 262 ScienceLeadR Reputation 1262
Network Map

Psychiatry

Subspecialties: Pharmacy - Psychology - Neurology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1992 - 2026

Source: PubMed

University of Montreal

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 440

Citations

Citations: 12 009 1st author: 91 Last author: 106 Unique author: 42


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Virtual Reality-Assisted Therapy Compared to Cognitive Behavioral Therapy for Patients With Treatment-Resistant Schizophrenia: Assessor-Blind Randomized Controlled Trial.
PMID 42748056 — virtual reality, hallucinations, psychotherapy, signs and symptoms, schizophrenia, clozapine, therapeutics, cognitive behavioral therapy, voice, schizophrenia, treatment-resistant
JMIR Ment Health20260
Suicidal ideation at psychiatric emergency presentation predicts trajectories of functional disability and symptom burden in mood and anxiety disorders: A prospective cohort study.
PMID 42700776 — emergencies, cohort studies, signs and symptoms, anxiety disorders, affective symptoms, suicidal ideation
J Affect Disord20260
Virtual Reality-Assisted Therapy Compared to Cognitive Behavioral Therapy for Patients with Treatment-Resistant Schizophrenia: A Randomized, Assessor-Blind Controlled Trial.
PMID 42671824 — virtual reality, hallucinations, signs and symptoms, schizophrenia, clozapine, therapeutics, cognitive behavioral therapy, voice, schizophrenia, treatment-resistant
JMIR Ment Health20260
L’ornithorynque et le thermomètre : réflexions sur les 30 ans du CR-IUSMM et les transformations contemporaines de la recherche en santé mentale.
PMID 42550431 — community mental health services
Sante Ment Que20260
[Allostatic Load and Transdiagnostic Dimensions in Patients Admitted to the Psychiatric Emergency Department: A Research Protocol Using the Signature Biobank].
PMID 42550439 — emergencies, stress, physiological, biomarkers, signs and symptoms, research, emergency service, hospital
Sante Ment Que20260

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2 Study Chair: 1

By phase:

Phase 4 3
N/A 2
Phase 3 2
Phase 2 1

By status:

Completed 5
Recruiting 2
Withdrawn 1

By type:

Interventional 8

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 1
multicentric5to9 0
multicentricup10 2

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders
NCT05704582 — virtual reality, mental disorders, marijuana abuse, psychotic disorders, mental health
N/ARecruiting2023

LeadR Networks

Main global connection map